Substance / Medication

Triprolidine

Overview

Active Ingredient
triprolidine
RxNorm CUI
10849

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of Triprolidine in the Treatment of Temporary Sleep Disturbance.
Cravo Ana Santos, Shephard Adrian, Shea Tim · J Clin Pharmacol · 2021
PMID: 33768603Observational
Solubility-modulated asymmetric membrane tablets of triprolidine hydrochloride: statistical optimization and evaluation.
Dev Rahul, Kumar Anil, Pathak Kamla · AAPS PharmSciTech · 2012
PMID: 22183255ObservationalFull text (PMC)
Simultaneous HPLC analysis of pseudophedrine hydrochloride, codeine phosphate, and triprolidine hydrochloride in liquid dosage forms.
Manassra Adnan, Khamis Mustafa, El-Dakiky Magdy et al. · J Pharm Biomed Anal · 2010
PMID: 19954915Observational
Simultaneous determination of triprolidine and pseudoephedrine in human plasma by liquid chromatography-ion trap mass spectrometry.
Shakya Ashok K, Arafat Tawfiq A, Abuawwad Ahmad N et al. · J Chromatogr B Analyt Technol Biomed Life Sci · 2009
PMID: 19926351Observational
Antihistamine effects of triprolidine from the transdermal administration of the TPX matrix in rats.
Shin Sang-Chul, Choi Jun-Shik · Arch Pharm Res · 2005
PMID: 15742818Observational
Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
Shin Sang-Chul, Lee Hyun-Jin · Eur J Pharm Biopharm · 2002
PMID: 12191692Observational
A retrospective review of Texas Poison Center Network experience with pediatric triprolidine exposures.
Miller Robert, Nguyen Thuy, Morrow Mark et al. · Clin Toxicol (Phila) · 2026
PMID: 41524505Other
The evaluation of photochemical behavior of antihistaminic drug triprolidine in an aqueous media.
Kawabata Kohei, Masumoto Misaki, Inagaki Masanori et al. · Anal Sci · 2023
PMID: 37679658Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Triprolidine (substance)
SNOMED CT
372678008
UMLS CUI
C0041098
RxNorm CUI
10849

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

5
Conditions
2
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.